| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/2008 | US20080171706 Anti-Adhesive Compounds to Prevent and Treat Bacterial Infections |
| 07/17/2008 | US20080171704 Composition and method for treating diabetes |
| 07/17/2008 | US20080171702 Novel gene and uses therefor |
| 07/17/2008 | US20080171701 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171691 Inhibition of invasive remodelling |
| 07/17/2008 | US20080171687 Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs |
| 07/17/2008 | US20080171657 5,6-Dialkyl-7-Aminoazolopyrimidines, Their Preparation and Their Use for Controlling Harmful Fungi, and Compositions Comprising These Compounds |
| 07/17/2008 | US20080171129 Drug eluting medical device using polymeric therapeutics with patterned coating |
| 07/17/2008 | US20080171097 Synergistic mixture of licorice root extract and oak bark and dexpanthenol; treatment of herpes virus and microorganism caused diseases; cosmetics, foods |
| 07/17/2008 | US20080171096 Method for Decreasing Nicotine and Other Substance Use in Humans |
| 07/17/2008 | US20080171091 Nanoparticulate compositions of immunosuppressive agents |
| 07/17/2008 | US20080171089 Stable anti-nausea oral spray formulations and methods |
| 07/17/2008 | US20080171088 Particles of megestrol, megestrol acetate and a surface stabilizer |
| 07/17/2008 | US20080171086 Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same |
| 07/17/2008 | US20080171085 Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration |
| 07/17/2008 | US20080171084 And two lipidic excipients, an oily vehicle, and glyceroyl macrogolglycerides or polyethyleneglycol; increased bioavailability |
| 07/17/2008 | US20080171082 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/17/2008 | US20080171081 Administering liposomes carrying phosphate-glycerol groups; inhibiting and/or reducing the progression of the T-cell function-mediated disorder; antiinflammatory |
| 07/17/2008 | US20080171078 Uniformly sized liposomes |
| 07/17/2008 | US20080171077 Method and apparatus for making uniformly sized particles |
| 07/17/2008 | US20080171075 Transdermal composition; amitriptyline, clonidine, ketamine, an anti-inflammatory, lecithin isopropyl palmitate oil; analgesic |
| 07/17/2008 | US20080171072 Ocular inserts containing apomorphine |
| 07/17/2008 | US20080171061 Using lentiviral peptide to ellicit CD8+ lymphocyte response to treat and prevent viral infection and viral associated cell proliferative disorders |
| 07/17/2008 | US20080171052 Hmgb1 protein inhibitorsand/or antagonists for the treatment of vascular diseases |
| 07/17/2008 | US20080171051 Cancer Treatment |
| 07/17/2008 | US20080171050 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 07/17/2008 | US20080171049 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171042 Using antisense agents to prevent/reduce cell surface glycoprotein expression and treat cell proliferative disorders of prostate gland |
| 07/17/2008 | US20080171034 2-Adamantyl-3-hydroxycyclopenta[a]phenanthren-17-yldeneimino-oxy, -amino- and -aminocarbonyl compounds; degenerative diseases including neurodegenerative; ophthalmic; cardiovascular; bone, joint, connective tissue or cartilage; & mitochondrial disorders; transplants; altered activity of excitotoxic path |
| 07/17/2008 | US20080171031 Compositions for Juice-Based Moisturizers |
| 07/17/2008 | US20080171027 Compositions and Methods for Elimination of Unwanted Cells |
| 07/17/2008 | US20080171026 Using recombinant cells expressing measles virus H glycoprotein to target tumor cells fusion and removal; tissue target therapy |
| 07/17/2008 | US20080171025 Using histidine and lysine (HK) as carrier sequences in small interfering RNA transfection complex; for use in prevention and treatment of cell proliferative, muscular, blood, respiratory and nervous system disorders |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080171015 Compounds for the Treatment of Hepatitis C |
| 07/17/2008 | US20080171013 Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugates thereof |
| 07/17/2008 | US20080171002 Immunostimulants; free of storage protein from nongerminated seeds of Ricinus communis (Castor bean); treating cancer, infections, and pathogenic diseases; AM3 as example; binds to dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN) |
| 07/17/2008 | US20080170999 Thienopyrimidines As Cooling Agents |
| 07/17/2008 | US20080170997 Compositions for the treatment and prevention of cancer |
| 07/17/2008 | US20080170995 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 07/17/2008 | US20080170993 Thymidine analogs for imaging |
| 07/17/2008 | US20080169215 Cosmetic compositions |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/17/2008 | DE202008005023U1 Verwendung von α-Liponsäure und Coenzym Q10 zur selektiven Reduktion des visceralen Fettgewebes Use of α-lipoic acid and coenzyme Q10 for the selective reduction of visceral adipose tissue |
| 07/17/2008 | DE102007002872A1 Use of avermectin with derivation of epi-methylamino group (emamectin) or epi-acetylamino group (epinomectin) and/or salts, for treatment of fish against parasites, nematode, Acanthocephala or Crustacea |
| 07/17/2008 | DE102007002170A1 Produkt Süßholzwurzel + Eichenrinde in Kombination mit Dexpanthenol Product licorice root + oak bark in combination with dexpanthenol |
| 07/17/2008 | CA2809276A1 Food products comprising a slowly digestable or digestion resistant carbohydrate composition |
| 07/17/2008 | CA2675334A1 Reducing side effects associated with ala-based photodynamic therapy |
| 07/17/2008 | CA2675288A1 Condensed pyridine compound |
| 07/17/2008 | CA2675132A1 Modulation of neurogenesis with use of modafinil |
| 07/17/2008 | CA2675111A1 Urea glucokinase activators |
| 07/17/2008 | CA2675029A1 Pharmaceutically active compounds |
| 07/17/2008 | CA2674998A1 Pyridine compounds and their use as p2y12 antagonists |
| 07/17/2008 | CA2674958A1 Spiropiperidine glycinamide derivatives |
| 07/17/2008 | CA2674843A1 Factor xa inhibitors |
| 07/17/2008 | CA2674787A1 Plant compositions enriched in dehydrosoyasaponin i (d-i) and methods of producing such compositions |
| 07/17/2008 | CA2674681A1 Medically active plaster for releasing an active compound that is liquid at room temperature |
| 07/17/2008 | CA2674647A1 Chemical compounds 637 |
| 07/17/2008 | CA2674644A1 Sulfonamide derivatives as chymase inhibitors |
| 07/17/2008 | CA2674604A1 Formulations of deacetylase inhibitors |
| 07/17/2008 | CA2674603A1 Sp35 antibodies and uses thereof |
| 07/17/2008 | CA2674492A1 Method for the treatment of conditions associated with increased 5-lipoxygenase and/or leukotriene activity |
| 07/17/2008 | CA2674460A1 3-substituted-h.2.31-benzotriazinone compound for enhancing glutamatergic synaptic responses |
| 07/17/2008 | CA2674389A1 Rho kinase inhibitors |
| 07/17/2008 | CA2674367A1 Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders |
| 07/17/2008 | CA2674325A1 Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method |
| 07/17/2008 | CA2674321A1 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses |
| 07/17/2008 | CA2674318A1 Cyclized derivatives as eg-5 inhibitors |
| 07/17/2008 | CA2674305A1 Therapy |
| 07/17/2008 | CA2674045A1 Tricyclic compound and pharmaceutical use thereof |
| 07/17/2008 | CA2674039A1 Sustained release formulation for tacrolimus |
| 07/17/2008 | CA2673888A1 Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/17/2008 | CA2673869A1 Method of treating multidrug resistant cancers |
| 07/17/2008 | CA2673803A1 Compounds and compositions as channel activating protease inhibitors |
| 07/17/2008 | CA2673683A1 Compounds and method for treatment of cancer |
| 07/17/2008 | CA2673654A1 5-pyridinone substituted indazoles |
| 07/17/2008 | CA2673653A1 Myocardial perfusion imaging |
| 07/17/2008 | CA2673652A1 Bis-aryl amide derivatives and methods of use |
| 07/17/2008 | CA2673649A1 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| 07/17/2008 | CA2673635A1 5-furopyridinone substituted indazoles |
| 07/17/2008 | CA2673058A1 Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate |
| 07/17/2008 | CA2672863A1 Effervescent formulations of florfenicol for addition in drinking water systems |
| 07/17/2008 | CA2672574A1 Silylated piperidine derivatives |
| 07/17/2008 | CA2672377A1 Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component |
| 07/17/2008 | CA2672307A1 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 07/17/2008 | CA2672230A1 Benzazepine compounds as cgrp receptor antagonists |
| 07/17/2008 | CA2672221A1 Anti-hypercholesterolemic compounds |
| 07/17/2008 | CA2672190A1 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands |
| 07/17/2008 | CA2671943A1 Compounds having both angiotensin ii receptor antagonism and ppary activating activities |
| 07/17/2008 | CA2671554A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition |
| 07/17/2008 | CA2671138A1 Inhibitors of serine palmitoyltransferase |
| 07/17/2008 | CA2670270A1 Use of iap inhibitors for the treatment of acute myeloid leukemia |
| 07/17/2008 | CA2637125A1 Food products comprising a slowly digestible or digestion resistant carbohydrate composition |
| 07/17/2008 | CA2618691A1 Methods for preventing, managing, and reversing disease caused by inflammation mediated vascular lesions |
| 07/16/2008 | EP1944607A2 Toluidine blue O compounds and their manufacture, analysis and use |
| 07/16/2008 | EP1944307A2 Synthetic Salicylihalamides, Apicularens and Derivatives Thereof |
| 07/16/2008 | EP1944306A1 Fused heterocyclic compounds as serotonin receptor modulators |
| 07/16/2008 | EP1944305A1 Quinoline derivatives as phosphodiesterase inhibitors |